Meta Biomed Co. Ltd (059210) — Capital Reinvestment Ratio
Meta Biomed Co. Ltd (059210) has a Capital Reinvestment Ratio of 4.21x as of September 2025, meaning it reinvests 4% of its operating cash flow (₩1.05 Billion) in capital expenditures (₩4.44 Billion). See Meta Biomed Co. Ltd net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Meta Biomed Co. Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Meta Biomed Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. Check 059210 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Meta Biomed Co. Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Meta Biomed Co. Ltd from 2011 to 2024. For live market cap and broader valuation context, see Meta Biomed Co. Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.49x | ₩22.63 Billion | ₩11.10 Billion | ▼ -56.4% |
| 2023 | 1.12x | ₩10.22 Billion | ₩11.49 Billion | ▼ -33.1% |
| 2022 | 1.68x | ₩9.16 Billion | ₩15.41 Billion | ▲ +806.2% |
| 2021 | 0.19x | ₩11.14 Billion | ₩2.07 Billion | ▼ -59.5% |
| 2020 | 0.46x | ₩4.86 Billion | ₩2.23 Billion | ▼ -82.6% |
| 2019 | 2.64x | ₩2.86 Billion | ₩7.56 Billion | ▲ +116.8% |
| 2016 | 1.22x | ₩5.03 Billion | ₩6.13 Billion | ▼ -22.9% |
| 2015 | 1.58x | ₩4.93 Billion | ₩7.79 Billion | ▲ +27.5% |
| 2013 | 1.24x | ₩3.71 Billion | ₩4.60 Billion | ▼ -9.7% |
| 2012 | 1.37x | ₩3.83 Billion | ₩5.26 Billion | ▼ -31.5% |
| 2011 | 2.00x | ₩4.10 Billion | ₩8.22 Billion | — |